Anika TherapeuticsANIK
那斯達克 · USD
9.56
+0.07
(+0.74%)
收盤 12/13 04:59 (UTC+8)
12/13 04:59 (UTC+8)
Anika TherapeuticsANIK
9.56
+0.07
(+0.74%)
財務數據
損益表
- 0.44
- 0.41
- 0.43
- 0.29
- 0.53
- 0.30
- 0.31
- 0.26
- 0.28
- 0.28
- 16.82
- -6.40
- 3.63
- -32.46
- 84.07
- -44.67
- -21.03
- -
- 7.84
- -1.42
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | 27,817 | 28,219 | 26,168 | 30,602 | 29,559 | 53,422 | 29,022 | 42,971 | 41,465 | 44,302 |
營業成本 | 12,233 | 13,856 | 11,487 | 13,476 | 10,151 | 20,404 | 10,047 | 16,642 | 16,521 | 15,330 |
營業毛利 | 15,584 | 14,363 | 14,681 | 17,126 | 19,408 | 33,018 | 18,975 | 26,329 | 24,944 | 28,972 |
營業費用 | 18,817 | 18,543 | - | 17,831 | 22,590 | 35,415 | - | 90,110 | 32,618 | 32,603 |
研發費用 | 6,946 | 6,313 | 6,059 | 6,507 | 5,946 | 9,153 | 6,409 | 7,585 | 7,791 | 8,914 |
推銷及管理費用 | 11,871 | 12,230 | 12,906 | 11,324 | 13,543 | 26,262 | 15,071 | 20,335 | 24,827 | 23,689 |
非經常性項目費用 | - | - | - | - | 3,101 | - | - | 62,190 | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -3,233 | -4,180 | -4,284 | -705 | -28,017 | -2,397 | -2,505 | -63,781 | -7,674 | -3,631 |
其他收入及費用 | 997 | - | - | - | 406 | - | - | - | 635 | - |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -2,236 | -3,966 | -3,869 | 39 | 325 | -1,802 | -1,913 | -63,204 | -7,039 | -3,070 |
所得稅 | 939 | 681 | 89 | 2,525 | 2,170 | 844 | 43 | -204 | -463 | -329 |
稅後純益 | -2,329 | -3,970 | -4,873 | -21,865 | -29,918 | -88 | -4,514 | -63,000 | -6,576 | -2,741 |
基本每股稅後盈餘(元) | -0.16 | -0.28 | -0.34 | -1.50 | -2.03 | -0.01 | -0.31 | -4.30 | -0.45 | -0.19 |
稀釋每股稅後盈餘(元) | -0.16 | -0.28 | -0.34 | -1.49 | -2.03 | 0.00 | -0.31 | -4.30 | -0.45 | -0.18 |
基本平均股數(千股) | 14419.00 | 14364.00 | 14297.00 | 14576.00 | 14768.00 | 14839.00 | 14698.00 | 14647.00 | 14635.00 | 14688.00 |
稀釋平均股數(千股) | 14419.00 | 14517.00 | 14297.00 | 14576.00 | 14768.00 | 14839.00 | 14698.00 | 14647.00 | 14635.00 | 14688.00 |
還原基本每股稅後盈餘(元) | -0.16 | -0.28 | -0.34 | -1.50 | -2.03 | -0.01 | -0.31 | -4.30 | -0.45 | -0.19 |
還原稀釋每股稅後盈餘(元) | -0.16 | -0.28 | -0.34 | -1.49 | -2.03 | 0.00 | -0.31 | -4.30 | -0.45 | -0.18 |
還原基本平均股數(千股) | 14,419 | 14,364 | 14,297 | 14,576 | 14,768 | 14,839 | 14,698 | 14,647 | 14,635 | 14,688 |
還原稀釋平均股數(千股) | 14,419 | 14,517 | 14,297 | 14,576 | 14,768 | 14,839 | 14,698 | 14,647 | 14,635 | 14,688 |
EBITDA(千元) | 13 | -1,873 | -3,192 | -17,528 | -25,560 | 2,814 | -2,408 | -59,630 | -3,497 | 480 |